In addition, histological analysis of metastatic pancreatic tumor outcomes showed that, dynamin 2 has elevated in 60 % of the metastatic tumors compared to benign tissues (Eppinga et al., 2012[6]). The gene discussed is DNM2; the disease is metastatic neoplasm.